Globus Medical (GMED) Raw Materials (2018 - 2025)

Globus Medical (GMED) has 8 years of Raw Materials data on file, last reported at $152.1 million in Q3 2025.

• For the quarter ending Q3 2025, Raw Materials rose 31.33% year-over-year to $152.1 million; the trailing twelve-month figure through Sep 2025 stood at $152.1 million (up 31.33% YoY), and the FY2024 full-year result was $122.0 million, up 18.03% from the prior year.
• Raw Materials for Q3 2025 stood at $152.1 million, down from $153.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $153.3 million in Q2 2025 and bottomed at $41.7 million in Q1 2021.
• The 5-year median for Raw Materials is $75.0 million (2023), against an average of $84.8 million.
• The widest annual swing landed in 2021, when Raw Materials advanced 5.48%; it then surged 71.32% in 2023.
• A 5-year view of Raw Materials shows it stood at $41.8 million in 2021, then soared by 44.25% to $60.3 million in 2022, then soared by 71.32% to $103.3 million in 2023, then rose by 18.03% to $122.0 million in 2024, then rose by 24.71% to $152.1 million in 2025.
• The last three Raw Materials figures came in at $152.1 million (Q3 2025), $153.3 million (Q2 2025), and $118.6 million (Q1 2025), per Business Quant data.

Peer Comparison